Virtually supported penicillin allergy de-labelling during COVID-19.

Arian GhassemianGeetanjalee SadiRaymond MakStephanie ErdleTiffany WongSamira Jeimy

Published in: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology (2023)

Virtual medicine is likely to remain in the allergist's practice. Virtually supported penicillin allergy delabelling, based on shared decision making and risk stratification, presents another pathway for penicillin allergy delabelling.

Keyphrases

atopic dermatitis
infectious diseases
primary care